PTF1A
Pancreas transcription factor 1 subunit alpha
Also known as: bHLHa29, p48, PTF1-p48, PTF1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7RTS3
- Gene
- PTF1A
- Ensembl
- ENSG00000168267
- Chromosome
- 10
- Canonical length
- 328 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a protein that is a component of the pancreas transcription factor 1 complex (PTF1) and is known to have a role in mammalian pancreatic development. The protein plays a role in determining whether cells allocated to the pancreatic buds continue towards pancreatic organogenesis or revert back to duodenal fates. The protein is thought to be involved in the maintenance of exocrine pancreas-specific gene expression including elastase 1 and amylase. Mutations in this gene cause cerebellar agenesis and loss of expression is seen in ductal type pancreas cancers. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
328 residues, UniProt reviewed canonical sequence.
>Q7RTS3|PTF1A
1 MDAVLLEHFP GGLDAFPSSY FDEDDFFTDQ SSRDPLEDGD ELLADEQAEV EFLSHQLHEY
61 CYRDGACLLL QPAPPAAPLA LAPPSSGGLG EPDDGGGGGY CCETGAPPGG FPYSPGSPPS
121 CLAYPCAGAA VLSPGARLRG LSGAAAAAAR RRRRVRSEAE LQQLRQAANV RERRRMQSIN
181 DAFEGLRSHI PTLPYEKRLS KVDTLRLAIG YINFLSELVQ ADLPLRGGGA GGCGGPGGGG
241 RLGGDSPGSQ AQKVIICHRG TRSPSPSDPD YGLPPLAGHS LSWTDEKQLK EQNIIRTAKV
301 WTPEDPRKLN SKSSFNNIEN EPPFEFVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTF1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 99 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 99 nTPM
- testis: 2 nTPM
- stomach: 1.9 nTPM
- basal ganglia: 0.7 nTPM
- cerebral cortex: 0.7 nTPM
- hippocampal formation: 0.4 nTPM
Single-cell type
- pancreatic acinar cells: 131 nCPM
- neuroendocrine cells: 30 nCPM
- late primary spermatocytes: 10 nCPM
- oocytes: 4.6 nCPM
- parietal cells: 3.5 nCPM
- early spermatids: 1.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 2.4 nTPM
- medulla oblongata: 1.3 nTPM
- pons: 1.3 nTPM
- hippocampal formation: 1 nTPM
- basal ganglia: 0.9 nTPM
- cerebellum: 0.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTF1A.
Disease | AllUniProt
Conditions PTF1A is implicated in, by any mechanism.
- Pancreatic and cerebellar agenesis (PACA) MIM:609069
- Pancreatic agenesis 2 (PAGEN2) MIM:615935
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 175 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome
- Pancreatic agenesis 2
- Kallikrein, decreased urinary activity of
- Syndromic Monogenic Diabetes
- Permanent neonatal diabetes mellitus
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0.17
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amacrine cell differentiation
- cerebellum development
- developmental process
- exocrine pancreas development
- neuron fate commitment
- pancreas development
- regulation of DNA-templated transcription
- regulation of neural retina development
- regulation of transcription by RNA polymerase II
- retina layer formation
- retinoic acid receptor signaling pathway
- tissue development
- transcription by RNA polymerase II
Molecular functions
- chromatin binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- E-box binding
- protein dimerization activity
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTF1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTF1A as an antibody target. Whether an autoantibody or antibody against PTF1A could matter depends on whether native PTF1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTF1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTF1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...